An Open-label, Long-term Extended Access Protocol for Rapastinel as Adjunctive or Monotherapy Treatment in Patients With Major Depressive Disorder
An Open-label, Long-term Extended Access Protocol for Rapastinel as Adjunctive or Monotherapy Treatment in Patients With Major Depressive Disorder
Multicenter, open-label, long-term extended access treatment protocol in adult patients with a primary diagnosis of MDD.
Inclusion Criteria:
Exclusion Criteria:
Suicide risk, as determined by meeting any of the following criteria:
At imminent risk of injuring self or others or causing significant damage to property, as judged by the investigator
Females who are pregnant, breastfeeding, or planning to become pregnant or breastfeed during participation
Females of childbearing potential and male partners of females of childbearing potential, not using a reliable means of contraception
Nashua, New Hampshire 03060, United States